Breaking News

Pharmasol Adds Quality & Regulatory Professionals

August 15, 2014

Vassilopoulo and Chaturvedi to head QA and QC

Cheryl Vassilopoulos has been appointed vice president of Quality & Regulatory Affairs at Pharmasol Corp.  Ms. Vassilopoulos has more than 20 years of experience in pharmaceutical analytical method development, quality control, and quality assurance management. Prior to joining the company, she served as vice president of Quality & Regulatory Compliance at Precision Dermatology, Inc.  Previously, she held positions of increasing responsibility at Collegium Pharmaceutical, Inc. and Copley Pharmaceutical, Inc., where she managed teams of method development chemists and quality assurance associates for a broad range of dosage forms.

Also joining the company from Precision Dermatology are Lisa Pezzullo and Pam Lounsbury, serving as QA Compliance Manager and QA Development Manager, respectively.

Additionally, Dr. Surendra Chaturvedi has been appointed director of Quality Control at Pharmasol. Dr. Chaturvedi has more than 25 years of experience in the pharma and biotech industries in areas including multiple organic syntheses, analytical method development, quality control and process development. Dr. Chaturvedi has also managed a manufacturing and analytical contract lab, as well as managed large groups of both organic and analytical chemists in synthesizing and characterizing APIs. He has more than 15 publications in peer-reviewed journals and has presented at various conferences. 

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016